COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

In a Plenary Paper, Mittelman and colleagues assess the relative clinical efficacy of mRNA vaccination on COVID-19 disease incidence and outcomes in patients with hematologic malignancies compared with healthy matched controls. This population-based study from Israel links prior observations of poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagano, Livio, Salmanton-García, Jon, Marchesi, Francesco, López-García, Alberto, Lamure, Sylvain, Itri, Federico, Gomes-Silva, Maria, Dragonetti, Giulia, Falces-Romero, Iker, van Doesum, Jaap, Sili, Uluhan, Labrador, Jorge, Calbacho, Maria, Bilgin, Yavuz M., Weinbergerová, Barbora, Serrano, Laura, Ribera-Santa Susana, José-María, Malak, Sandra, Loureiro-Amigo, José, Glenthøj, Andreas, Córdoba-Mascuñano, Raúl, Nunes-Rodrigues, Raquel, González-López, Tomás-José, Karlsson, Linda Katharina, Jiménez-Lorenzo, María-Josefa, Hernández-Rivas, José-Ángel, Jaksic, Ozren, Ráčil, Zdeněk, Busca, Alessandro, Corradini, Paolo, Hoenigl, Martin, Klimko, Nikolai, Koehler, Philipp, Pagliuca, Antonio, Passamonti, Francesco, Cornely, Oliver A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Letters to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577877/
https://www.ncbi.nlm.nih.gov/pubmed/34748627
http://dx.doi.org/10.1182/blood.2021014124

Ejemplares similares

Ejemplares similares